InvestorsHub Logo
Followers 51
Posts 9141
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Friday, 03/17/2023 12:31:25 AM

Friday, March 17, 2023 12:31:25 AM

Post# of 13522
These vaccine candidates for respiratory syncytial virus (RSV), cytomegalovirus (CMV), and flu are in phase 3 trials. So they're approaching the finish line. In fact, Moderna aims to file for regulatory approval of the RSV candidate by the end of the first half of this year.

$MRNA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News